Prevalence of physician-documented beta-lactam allergy in Canadian primary care practices

Research conducted in the U.S has determined the prevalence of reported beta-lactam allergy to be between 10-17%. Currently, there is a lack of available Canadian data on beta-lactam allergy prevalence. The purpose of this study is to describe the prevalence of physician documented beta-lactam allergies in a Canadian outpatient population and to comment on associated characteristics of patients and providers.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research